ANGIOSTATIN

pharmaceutical preparations, namely anti-angiogenic protein compositions for the treatment of diseases and biological processes that are mediated by angiogenesis, namely cancer, macular degeneration, diabetic retinopathy, Crohn's disease, psoriasis and arthritis